Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

NCT00688415 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene